The FDA has issued a warning letter to Torrent Pharmaceuticals regarding problems at a losartan manufacturing plant in India as part of its investigation into contaminated hypertension drugs.…
A new analysis warns that the FDA has only screened a quarter of all valsartan and similar high blood pressure medications for cancer-causing impurities.…
The federal judge overseeing valsartan recall litigation has approved Plaintiff Fact Sheets for both individual and class action claims that the generic hypertension drugs contained cancer-causing impurities.…
The hypertension drug Benicar has been linked to cases of sprue-like enteropathy, which causes chronic diarrhea, weight gain and other serious gastrointestinal problems.…
In July 2018, it was discovered that certain generic valsartan pills sold for years may contain impurities that increase the risk of users developing liver cancer, kidney cancer and other side effects. …
A status conference this week will discuss whether losartan and irbesartan lawsuits should be added to a valsartan recall lawsuit MDL, as all three drugs saw massive recalls over cancer-causing impurities.…
A losartan lawsuit claims generic versions of the drug were tainted with impurities which caused colon cancer.…
The FDA is expanding its hunt for cancer-causing impurities in drugs beyond hypertension medications like valsartan.…
A wrongful death lawsuit names a large number of generic drug manufacturers as liable for the death of a Texas man who contracted a fatal case of gastric cancer after consuming generic valsartan which was later recalled due to cancer-causing impurities.…
A court order calls for all valsartan lawsuits to be filed using short-form complaints to help the court coordinate and categorize the increasing flow of lawsuits over the recalled generic hypertension drugs.…
